Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients
- PMID: 16463425
- DOI: 10.1002/art.21699
Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients
Abstract
Objective: To study fluorodeoxyglucose (FDG) uptake in the different vascular beds and in the large joints of patients with giant cell arteritis (GCA) at diagnosis, during steroid treatment, and at relapse.
Methods: All consecutive patients admitted to our department with a diagnosis of GCA underwent FDG-positron emission tomography (PET) scan before treatment with methylprednisolone was started. PET scans were repeated at 3 and 6 months, if the initial PET scans showed vascular FDG uptake. PET scans were scored at 7 different vascular areas and a total vascular score (TVS) was calculated, ranging from 0 to 21.
Results: A total of 35 patients entered the study. At diagnosis, vascular FDG uptake was noted in 29 patients (83%), especially in the subclavian arteries (74%), but also in the aorta (>50%) and up to the femoral arteries (37%). TVS decreased from a mean +/- SD score of 7.9 +/- 5.5 at baseline to 2.4 +/- 3.5 on repeat PET scan at 3 months (P < 0.0005), but did not further decrease at 6 months. The patients who relapsed had similar earlier decreases of TVS compared with those who did not relapse. FDG uptake in the shoulders at diagnosis correlated significantly with the presence of polymyalgia rheumatica (P = 0.005).
Conclusion: FDG uptake in the large vessels is a sensitive marker for GCA, which can involve the larger thoracic, abdominal, and peripheral arteries. Polymyalgia rheumatica symptoms in patients with GCA correlate with (peri)synovitis of the shoulders. Relapses of GCA cannot be predicted by results of former PET scintigraphies.
Similar articles
-
Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients.Rheumatology (Oxford). 2007 Apr;46(4):672-7. doi: 10.1093/rheumatology/kel376. Epub 2006 Nov 18. Rheumatology (Oxford). 2007. PMID: 17114803
-
Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia rheumatica, giant cell arteritis and fever of unknown origin.Clin Exp Rheumatol. 2023 Apr;41(4):812-820. doi: 10.55563/clinexprheumatol/uq9p1q. Epub 2023 Apr 18. Clin Exp Rheumatol. 2023. PMID: 37073635
-
Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis.Mod Rheumatol. 2012 Sep;22(5):705-11. doi: 10.1007/s10165-011-0581-x. Epub 2011 Dec 29. Mod Rheumatol. 2012. PMID: 22205118
-
Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography.Biomed Res Int. 2014;2014:574248. doi: 10.1155/2014/574248. Epub 2014 Sep 1. Biomed Res Int. 2014. PMID: 25254211 Free PMC article. Review.
-
Imaging for large-vessel vasculitis.Curr Opin Rheumatol. 2009 Jan;21(1):19-28. doi: 10.1097/BOR.0b013e32831cec7b. Curr Opin Rheumatol. 2009. PMID: 19077714 Review.
Cited by
-
Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study.Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1012-24. doi: 10.1007/s00259-015-3007-8. Epub 2015 Apr 16. Eur J Nucl Med Mol Imaging. 2015. PMID: 25876704
-
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis.Diagnostics (Basel). 2022 Nov 7;12(11):2717. doi: 10.3390/diagnostics12112717. Diagnostics (Basel). 2022. PMID: 36359560 Free PMC article.
-
The Role of Vascular Imaging to Advance Clinical Care and Research in Large-Vessel Vasculitis.Curr Treatm Opt Rheumatol. 2019 Mar;5(1):20-35. doi: 10.1007/s40674-019-00114-0. Epub 2019 Feb 9. Curr Treatm Opt Rheumatol. 2019. PMID: 31598465 Free PMC article.
-
The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist.Rheumatology (Oxford). 2018 Feb 1;57(2):227-235. doi: 10.1093/rheumatology/kex173. Rheumatology (Oxford). 2018. PMID: 28460064 Free PMC article. Review.
-
Use of 18F-fluorodeoxyglucose positron emission tomography to monitor tocilizumab effect on vascular inflammation in giant cell arteritis.Rheumatology (Oxford). 2021 Sep 1;60(9):4384-4389. doi: 10.1093/rheumatology/keaa894. Rheumatology (Oxford). 2021. PMID: 33369678 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical